Role of Oral Corticosteroids in Treatment of Home Isolated COVID-19 Patients | ||
| Egyptian Journal of Medical Microbiology | ||
| Article 3, Volume 30, Issue 4, October 2021, Pages 19-24 PDF (225.48 K) | ||
| Document Type: New and original researches in the field of Microbiology. | ||
| DOI: 10.21608/ejmm.2021.197450 | ||
| Authors | ||
| Mohammed A. Aboelmagd1; Mariam Hassan* 2; Eman R. Hamed3; Mohamed M. Abdo4; Nageh Louis1 | ||
| 1Lecturer of Endemic and Infectious Diseases, Faculty of Medicine, Suez Canal University, Ismailia, Egypt | ||
| 2Resident of Gastroenterology, Ahmed Maher Teaching Hospital, Cairo, Egypt | ||
| 3Assistant Professor of Pulmonary Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt | ||
| 4Assistant Professor of Internal Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt | ||
| Abstract | ||
| Background: There is a debate over the efficacy of corticosteroids (CS) in management of Coronavirus diseases 2019 (COVID-19); yet, few are declared about its role in treatment of mild conditions. Objectives: in this study, we aimed at investigating the role of corticosteroids in mild cases of COVID-19. Methodology: in a case control study, we included 100 patients with mild COVID-19. The incidence of improvement, disappearance of symptoms, appearance of new symptoms and deterioration were compared between cases and control group. Results: More than three fourths of the study participants showed improvement of symptoms, with disappearance of symptoms in 64% and 85% of group 1 and group 2, respectively. Only few numbers of patients deteriorated. Noticeably, a remarkable number of patients expressed new symptoms by the end of the study. Conclusions: corticosteroids has no role in clinical progression of cases with mild COVID-19. CS use should be reserved for severe symptoms of COVID-19. | ||
| Keywords | ||
| COVID-19; Corona virus; SARS-CoV-2; Corticosteroids | ||
|
Statistics Article View: 618 PDF Download: 966 |
||
